Behandlung uroonkologischer Patienten
摘要
The treatment of uro-oncological malignancies is becoming increasingly individualized and thus more complex. New data on systemic therapy for urothelial, prostate and renal cell carcinomas, as well as on surgical and radiotherapeutic options for male germ cell tumors enrich the therapeutic spectrum in uro-oncology in general. On the one hand, this promotes increasing interdisciplinary care for patients and, on the other hand, requires increasing specialization of the treating physicians. The most important data on uro-oncological malignancies from the last year are summarized and an overview of their significance for clinical practice is provided.